106 related articles for article (PubMed ID: 7693820)
1. Immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach.
Groome N; O'Brien M
J Immunol Methods; 1993 Oct; 165(2):167-76. PubMed ID: 7693820
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal and polyclonal antibodies reactive with the 1-32 amino terminal sequence of the alpha subunit of human 32K inhibin.
Groome N; Hancock J; Betteridge A; Lawrence M; Craven R
Hybridoma; 1990 Feb; 9(1):31-42. PubMed ID: 1690174
[TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive two-site assays for inhibin-A and activin-A using monoclonal antibodies raised to synthetic peptides.
Groome N
J Immunol Methods; 1991 Dec; 145(1-2):65-9. PubMed ID: 1765667
[TBL] [Abstract][Full Text] [Related]
4. Development of a two-site immunoradiometric assay for dimeric inhibin using antibodies against chemically synthesized fragments of the alpha and beta subunit.
Knight PG; Groome N; Beard AJ
J Endocrinol; 1991 May; 129(2):R9-12. PubMed ID: 2040852
[TBL] [Abstract][Full Text] [Related]
5. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid.
Knight PG; Muttukrishna S; Groome NP
J Endocrinol; 1996 Feb; 148(2):267-79. PubMed ID: 8699141
[TBL] [Abstract][Full Text] [Related]
6. Measurement of dimeric inhibin B throughout the human menstrual cycle.
Groome NP; Illingworth PJ; O'Brien M; Pai R; Rodger FE; Mather JP; McNeilly AS
J Clin Endocrinol Metab; 1996 Apr; 81(4):1401-5. PubMed ID: 8636341
[TBL] [Abstract][Full Text] [Related]
7. Development of a specific and sensitive two-site enzyme-linked immunosorbent assay for measurement of inhibin-A in serum.
Baly DL; Allison DE; Krummen LA; Woodruff TK; Soules MR; Chen SA; Fendly BM; Bald LN; Mathers JP; Lucas C
Endocrinology; 1993 May; 132(5):2099-108. PubMed ID: 8477659
[TBL] [Abstract][Full Text] [Related]
8. Preparation of monoclonal antibodies to the beta A subunit of ovarian inhibin using a synthetic peptide immunogen.
Groome N; Lawrence M
Hybridoma; 1991 Apr; 10(2):309-16. PubMed ID: 1714879
[TBL] [Abstract][Full Text] [Related]
9. Development of an inhibin alpha subunit ELISA with broad specificity.
Robertson DM; Stephenson T; Cahir N; Tsigos A; Pruysers E; Stanton PG; Groome N; Thirunavukarasu P
Mol Cell Endocrinol; 2001 Jun; 180(1-2):79-86. PubMed ID: 11451575
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
[TBL] [Abstract][Full Text] [Related]
11. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
[TBL] [Abstract][Full Text] [Related]
12. A two-site enzyme-linked immunosorbent assay for inhibin.
Betteridge A; Craven RP
Biol Reprod; 1991 Nov; 45(5):748-54. PubMed ID: 1721843
[TBL] [Abstract][Full Text] [Related]
13. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay.
Lambert-Messerlian GM; Hall JE; Sluss PM; Taylor AE; Martin KA; Groome NP; Crowley WF; Schneyer AL
J Clin Endocrinol Metab; 1994 Jul; 79(1):45-50. PubMed ID: 8027251
[TBL] [Abstract][Full Text] [Related]
14. Development of a new antibody to the human inhibin/activin betaB subunit and its application to improved inhibin B ELISAs.
Ludlow H; Muttukrishna S; Hyvönen M; Groome NP
J Immunol Methods; 2008 Jan; 329(1-2):102-11. PubMed ID: 17991484
[TBL] [Abstract][Full Text] [Related]
15. Biological and immunological characterization of inhibin forms in human plasma.
Robertson D; Burger HG; Sullivan J; Cahir N; Groome N; Poncelet E; Franchimont P; Woodruff T; Mather JP
J Clin Endocrinol Metab; 1996 Feb; 81(2):669-76. PubMed ID: 8636287
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid.
Sugino K; Nakamura T; Takio K; Miyamoto K; Hasegawa Y; Igarashi M; Titani K; Sugino H
Endocrinology; 1992 Feb; 130(2):789-96. PubMed ID: 1733725
[TBL] [Abstract][Full Text] [Related]
17. Quantification of inhibin pro-alpha C-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay.
Groome NP; Illingworth PJ; O'Brien M; Priddle J; Weaver K; McNeilly AS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2926-32. PubMed ID: 7559876
[TBL] [Abstract][Full Text] [Related]
18. Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidized (Met O) inhibin.
Knight PG; Muttukrishna S
J Endocrinol; 1994 Jun; 141(3):417-25. PubMed ID: 8071641
[TBL] [Abstract][Full Text] [Related]
19. Development of a two-site solid-phase immunochemiluminescent assay for measurement of dimeric inhibin-A in human serum and other biological fluids.
McConnell DS; Padmanabhan V; Pollak TB; Groome NP; Ireland JJ; Midgley AR
Clin Chem; 1996 Aug; 42(8 Pt 1):1159-67. PubMed ID: 8697571
[TBL] [Abstract][Full Text] [Related]
20. Inhibin as a marker for ovarian cancer.
Cooke I; O'Brien M; Charnock FM; Groome N; Ganesan TS
Br J Cancer; 1995 May; 71(5):1046-50. PubMed ID: 7734297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
